Firefly Neuroscience, Inc. (AIFF) Stock

Technology · Software - Application · Member of Other US Stocks

Firefly Neuroscience, Inc. (AIFF) closed at USD 1.10 on 2026-10-15, a change of -42.7 % over the past year, with a market capitalization of USD 16M.

Firefly Neuroscience, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Firefly Neuroscience, Inc. key figures

Previous close

USD 1.10 (2026-10-15)

1-year change

-42.7 %

Market cap

USD 16M

Enterprise value

USD 6.78M

P/E ratio (trailing)

-1.73

P/E ratio (forward)

n/a

EPS (trailing)

-0.59

EPS (forward)

n/a

PEG ratio

n/a

Price to book

1.09

Revenue growth

71.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.15

Employees

17

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Firefly Neuroscience, Inc. and compare it with other stocks.